Incannex Healthcare Halted, News Pending
Investing.com -- HCA Healthcare, Inc. reported second-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $6.84, beating estimates by $0.57, while revenue reached $18.61 billion, surpassing the consensus estimate of $18.49 billion.
The healthcare provider’s revenue increased 6.4% compared to the same quarter last year, while net income attributable to HCA Healthcare (NYSE:HCA) rose 13.1% to $1.653 billion. Adjusted EBITDA grew 8.4% to $3.849 billion.
The company’s stock edged up 0.8% following the announcement.
Same facility admissions increased 1.8% and equivalent admissions grew 1.7% compared to the second quarter of 2024. Emergency room visits rose 1.3%, though inpatient and outpatient surgeries declined slightly by 0.3% and 0.6% respectively. Revenue per equivalent admission increased 4.0% YoY.
"We are pleased to report strong financial results for the second quarter. They reflected solid revenue growth, improved margins, and better outcomes for our patients," said Sam Hazen, Chief Executive Officer of HCA Healthcare.
The company generated $4.21 billion in operating cash flow during the quarter, more than double the $1.97 billion reported in the same period last year. HCA declared a quarterly dividend of $0.72 per share.
HCA raised its full-year 2025 guidance, now projecting revenue between $74.0 billion and $76.0 billion, up from its previous range of $72.8 billion to $75.8 billion. The company also increased its adjusted EBITDA forecast to between $14.7 billion and $15.3 billion, and now expects diluted EPS of $25.50 to $27.00, compared to the previous range of $24.05 to $25.85.
Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 billion.